InnovAge (OTCMKTS:INNV) Share Price Passes Above 50 Day Moving Average - Here's Why

Key Points

• InnovAge Holding Corp. shares surpassed their 50-day moving average of $4.18, reaching a trading high of $5.96.
• The company, with a market cap of $792.13 million, focuses on providing medical and ancillary services for seniors through its PACE program.
• InnovAge has a debt-to-equity ratio of 0.25 and a negative PE ratio of -18.84, indicating financial challenges despite its recent stock performance.

Shares of InnovAge Holding Corp. (OTCMKTS:INNV - ) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $4.18 and traded as high as $5.96. InnovAge shares last traded at $5.84, with a volume of 83,577 shares traded.

InnovAge Price Performance

The business has a fifty day simple moving average of $4.18 and a two-hundred day simple moving average of $3.79. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25. The stock has a market cap of $792.13 million, a PE ratio of -18.84 and a beta of 0.60.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.